Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × Hydroxyurea × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 4 Squamous Cell Carcinoma of Head and Neck 3 Polycythemia Vera 2 Meningioma 2 Treatment-Refractory Solid Tumors 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Chronic 1 Head and Neck Neoplasms 1 HPV-Negative Squamous Cell Carcinoma 1 Carcinoma, Squamous Cell 1 Bone Marrow Neoplasms 1 Bites and Stings 1

Interventions

trametinib 5 dabrafenib 5 pembrolizumab 2 cobimetinib 2 atezolizumab 2 Vemurafenib 2 Radiotherapy, Intensity-Modulated 2 Paclitaxel 2 zimberelimab 1 tislelizumab 1 surufatinib 1 selpercatinib 1 lenvatinib 1 fludarabine 1 cemiplimab 1 cabozantinib 1 aldesleukin 1 abemaciclib 1 Taxes 1 Nivolumab 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡